Literature DB >> 6865952

Immunochemical studies of yellowjacket venom proteins.

T P King, A C Alagon, J Kuan, A K Sobotka, L M Lichtenstein.   

Abstract

The major proteins of yellowjacket venoms have been isolated and characterized immuno-chemically. They consist of hyaluronidase, phospholipase, and antigen 5. Venoms from three species of yellowjacket were studied. Vespula germanica, V. maculifrons, and V. vulgaris. The phospholipases could be isolated in good yield only when affinity chromatography was used to minimize limited proteolysis. A kallikrein-like peptidase was found present in the yellowjacket venom. Phospholipases from these three species were immunochemically indistinguishable from each other, as were their antigen 5s. Sera from individuals sensitive to yellowjacket venom contained IgE and IgG specific for antigen 5 and phospholipase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865952     DOI: 10.1016/0161-5890(83)90069-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

Review 1.  Hymenoptera venom allergens.

Authors:  Donald R Hoffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

2.  Allergens of hymenopteran venoms.

Authors:  T P King; M D Valentine
Journal:  Clin Rev Allergy       Date:  1987-05

Review 3.  Standardized extracts. Stinging and biting insects.

Authors:  D R Hoffman; D B Golden
Journal:  Clin Rev Allergy       Date:  1987-02

4.  [Cross reactions between Hymenoptera venoms from different families, genera and species].

Authors:  W Hemmer
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

5.  Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.

Authors:  Henning Seismann; Simon Blank; Liliana Cifuentes; Ingke Braren; Reinhard Bredehorst; Thomas Grunwald; Markus Ollert; Edzard Spillner
Journal:  Clin Mol Allergy       Date:  2010-04-01

6.  Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.

Authors:  Birgit Winkler; Caroline Bolwig; Ulla Seppälä; Michael D Spangfort; Christof Ebner; Ursula Wiedermann
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

7.  Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae.

Authors:  Irina Borodina; Bettina M Jensen; Ib Søndergaard; Lars K Poulsen
Journal:  Microb Cell Fact       Date:  2010-09-24       Impact factor: 5.328

8.  Expression of enzymatically inactive wasp venom phospholipase A1 in Pichia pastoris.

Authors:  Irina Borodina; Bettina M Jensen; Tim Wagner; Maher A Hachem; Ib Søndergaard; Lars K Poulsen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 9.  Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens.

Authors:  Amilcar Perez-Riverol; Débora Lais Justo-Jacomini; Ricardo de Lima Zollner; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2015-07-09       Impact factor: 4.546

Review 10.  Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.

Authors:  Troy Wanandy; Emily Mulcahy; Wun Yee Lau; Simon G A Brown; Michael D Wiese
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-01       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.